These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2534469)

  • 1. [3H]S-145 and [125I]I-S-145-OH: new radioligands for platelet thromboxane A2 receptor with low nonspecific binding and high binding affinity for various receptor preparations.
    Ushikubi F; Nakajima M; Yamamoto M; Ohtsu K; Kimura Y; Okuma M; Uchino H; Fujiwara M; Narumiya S
    Eicosanoids; 1989; 2(1):21-7. PubMed ID: 2534469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
    Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
    J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro activity of various derivatives of a novel thromboxane receptor antagonist, (+/-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo[2.2.1] hept-2-exo-yl]heptenoic acid.
    Narisada M; Ohtani M; Watanabe F; Uchida K; Arita H; Doteuchi M; Hanasaki K; Kakushi H; Otani K; Hara S
    J Med Chem; 1988 Sep; 31(9):1847-54. PubMed ID: 2970551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
    Masuda A; Mais DE; Oatis JE; Halushka PV
    Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
    Dorn GW
    J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved synthesis of (5Z)-7-(3-endo-[(benzenesulfonamido)-bicyclo[2.2.1]heptyl]hept-5-enoic acid (S-145) derivatives and their iodine-125-labeled radioligands for the study of thromboxane A2 receptor.
    Kan WM; Tai HH
    Chem Phys Lipids; 1993 Apr; 65(1):57-64. PubMed ID: 8348677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
    Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
    J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145.
    Hanasaki K; Nagasaki T; Arita H
    Biochem Pharmacol; 1989 Jun; 38(12):2007-17. PubMed ID: 2525906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and localization of thromboxane A2 receptor in human and guinea-pig nasal mucosa using radiolabelled (+)-S-145.
    Arimura A; Miwa M; Hasegawa H; Kishino J; Notoya M; Yasui K; Komori M; Iwata S
    Br J Pharmacol; 1998 Jun; 124(4):795-803. PubMed ID: 9690873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.
    Schrör K; Davis-Bruno K; Halushka PV
    Biochem Pharmacol; 1995 Mar; 49(7):921-7. PubMed ID: 7741764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
    Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
    Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
    Mais DE; Kochel PJ; Saussy DL; Halushka PV
    Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane A2 receptor characterization in human astrocytoma cells and rabbit platelets by a new thromboxane antagonist, [3H]ONO NT-126.
    Takano S; Ishimoto H; Nakahata N; Nakanishi H
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):155-70. PubMed ID: 1534919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach for the study of thromboxane A2 and prostaglandin H2 receptors using an 125I-labeled ligand.
    Halushka PV; MacDermot J; Knapp DR; Eller T; Saussy DL; Mais D; Blair IA; Dollery CT
    Biochem Pharmacol; 1985 Apr; 34(8):1165-70. PubMed ID: 2986639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of (5Z)-7-[3-endo-[(4-iodophenylsulfonyl) amino] -bicyclo[2.2.1]hep-2-exo-yl]heptenoic acid (IS-145) as an antagonist for the study of thromboxane A2 receptor.
    Kan WM; Tai HH
    Prostaglandins Leukot Essent Fatty Acids; 1993 Jun; 48(6):439-45. PubMed ID: 8341721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.
    Hedberg A; Hall SE; Ogletree ML; Harris DN; Liu EC
    J Pharmacol Exp Ther; 1988 Jun; 245(3):786-92. PubMed ID: 2968449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets.
    Folger WH; Halushka PV; Wilcox CS; Guzman NJ
    Eur J Pharmacol; 1992 Sep; 227(1):71-8. PubMed ID: 1426024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a new compound, S-145, as a specific TXA2 receptor antagonist in platelets.
    Hanasaki K; Arita H
    Thromb Res; 1988 May; 50(3):365-76. PubMed ID: 2839912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.